🇪🇺 Oxbryta in European Union

EMA authorised Oxbryta on 17 March 2022

Marketing authorisation

EMA — authorised 17 March 2022

  • Local brand name: Oxbryta
  • Status: approved

Oxbryta in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Hematology approved in European Union

Frequently asked questions

Is Oxbryta approved in European Union?

Yes. EMA authorised it on 17 March 2022.

Who is the marketing authorisation holder for Oxbryta in European Union?

Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.